The regulatory role of dopamine receptor D1 on PP2A via SUMO-1 modification.
Renal dopamine receptor D1 played a critical role in the regulation of body blood pressure. Under hypertension, over-phosphorylation of D1 receptor impaired its function. G protein kinase 4 (GRK4) and protein phosphatase 2A (PP2A) exerted the effect to phosphorylate and de-phosphorylate D1 receptor. A current study revealed that the inhibition of GRK4 cannot normalize the phosphorylation level of D1 receptor. Meanwhile, the PP2A was activated under hypertension, indicating abnormal de-phosphorylation function of D1 receptor, the reason for which remains unknown. This study aimed to investigate the effect and mechanism of SUMO-1 modification on the regulation of dopamine receptor D1 to PP2A. Bioinformatics software predicted SUMO modification site in dopamine receptor D1. Cultured CHO cells were transfected with mutants of renal dopamine receptor D1. Co-immunoprecipitation and Western blot tested the interaction between over-phosphorylated D1 receptor and PP2A. Laser confocal microscopy examined their co-localization. Bioinformatics predicted two SUMO modification sites K265 and K402 in dopamine receptor D1. Co-immunoprecipitation assay revealed weakened interaction between PP2A and phosphorylated D1 receptor, impeding the de-phosphorylation and normal function of D1 receptor. Two SUMO modification sites existed in dopamine receptor D1, the phosphorylation of which, due to SUMO modification, can interact with PP2A, leading to the inhibition of D1 de-phosphorylation and normal function, thus providing new insights for treatment and prevention of hypertension.